Patent · US Active

Fusion proteins

US7659092B2 · kind B2 · utility

31Cited by
16References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 6, 2007
Grant dateFeb 9, 2010
Priority date
Expiry dateAug 18, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/06
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.